Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride is high-risk for cognitive disorders, while Carbidopa/Levodopa, Topiramate, and Clonazepam are moderate-risk.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

An 8-year-old girl's eyebrow hair loss was linked to atomoxetine for ADHD but grew back after stopping the medication.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Clascoterone cream 1% is effective and well-tolerated for treating acne and other related conditions.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Acitretin effectively treats severe hypertrophic lichen planus.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Dermatologists in Western Rajasthan often prescribe doxepin for elderly patients with skin and mental health issues.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.